Skip to main content
Erschienen in: Intensive Care Medicine 10/2018

06.08.2018 | Understanding the Disease

Understanding conflicts of interest

verfasst von: Per Olav Vandvik, Waleed Alhazzani, Morten Hylander Møller

Erschienen in: Intensive Care Medicine | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Excerpt

In the era of evidence-based medicine, clinical decisions about diagnosis and treatment should be informed by best current evidence integrated with clinical expertise and patient values, preferences and experiences [1]. However, conflicts of interest (COIs) could have a detrimental effect on the synthesis, interpretation and application of evidence in the field of intensive care medicine and in healthcare in general [2, 3]. These effects can be complex and difficult to characterise; therefore, better understanding is crucial. Indeed, evidence is open for interpretation. For example, the design, execution, or interpretation of randomised clinical trials (RCTs) and systematic reviews can be affected by various types of COIs (e.g., financial COIs). Similarly, recommendations in clinical practice guidelines can be highly influenced by unmanaged COIs [46]. Furthermore, COIs may affect decision making in daily clinical practice and in quality improvement initiatives, e.g. through flawed performance measures [7]. Also, non-transparent declaration and management of COIs could result in erosion of trust at governmental, institutional, and individual levels. …
Literatur
1.
Zurück zum Zitat Djulbegovic B, Guyatt GH (2017) Progress in evidence-based medicine: a quarter century on. Lancet 390:415–423CrossRef Djulbegovic B, Guyatt GH (2017) Progress in evidence-based medicine: a quarter century on. Lancet 390:415–423CrossRef
2.
Zurück zum Zitat Eichacker PQ, Natanson C, Danner RL (2006) Surviving sepsis–practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355:1640–1642CrossRef Eichacker PQ, Natanson C, Danner RL (2006) Surviving sepsis–practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355:1640–1642CrossRef
3.
Zurück zum Zitat Steinbrook R (2009) Controlling conflict of interest–proposals from the Institute of Medicine. N Engl J Med 360:2160–2163CrossRef Steinbrook R (2009) Controlling conflict of interest–proposals from the Institute of Medicine. N Engl J Med 360:2160–2163CrossRef
4.
Zurück zum Zitat Ioannidis JP (2016) Why most clinical research is not useful. PLoS Med 13:e1002049CrossRef Ioannidis JP (2016) Why most clinical research is not useful. PLoS Med 13:e1002049CrossRef
5.
Zurück zum Zitat Ioannidis JP (2016) The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q 94:485–514CrossRef Ioannidis JP (2016) The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q 94:485–514CrossRef
6.
Zurück zum Zitat Schunemann HJ, Al-Ansary LA, Forland F, Kersten S, Komulainen J, Kopp IB, Macbeth F, Phillips SM, Robbins C, van der Wees P, Qaseem A, Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines (2015) Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med 163:548–553CrossRef Schunemann HJ, Al-Ansary LA, Forland F, Kersten S, Komulainen J, Kopp IB, Macbeth F, Phillips SM, Robbins C, van der Wees P, Qaseem A, Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines (2015) Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med 163:548–553CrossRef
7.
Zurück zum Zitat Wachter RM, Flanders SA, Fee C, Pronovost PJ (2008) Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med 149:29–32CrossRef Wachter RM, Flanders SA, Fee C, Pronovost PJ (2008) Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med 149:29–32CrossRef
8.
Zurück zum Zitat Schunemann HJ, Osborne M, Moss J, Manthous C, Wagner G, Sicilian L, Ohar J, McDermott S, Lucas L, Jaeschke R, Ethics ATS, Conflict of Interest C, the Documents D, Implementation C (2009) An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med 180:564–580CrossRef Schunemann HJ, Osborne M, Moss J, Manthous C, Wagner G, Sicilian L, Ohar J, McDermott S, Lucas L, Jaeschke R, Ethics ATS, Conflict of Interest C, the Documents D, Implementation C (2009) An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med 180:564–580CrossRef
9.
Zurück zum Zitat Laine C, Taichman DB, Mulrow C (2011) Trustworthy clinical guidelines. Ann Intern Med 154:774–775CrossRef Laine C, Taichman DB, Mulrow C (2011) Trustworthy clinical guidelines. Ann Intern Med 154:774–775CrossRef
10.
Zurück zum Zitat Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, Lewis SZ, Nathanson I, Jaeschke R, Schunemann H (2010) The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 152:738–741CrossRef Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, Lewis SZ, Nathanson I, Jaeschke R, Schunemann H (2010) The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 152:738–741CrossRef
Metadaten
Titel
Understanding conflicts of interest
verfasst von
Per Olav Vandvik
Waleed Alhazzani
Morten Hylander Møller
Publikationsdatum
06.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 10/2018
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-018-5338-y

Weitere Artikel der Ausgabe 10/2018

Intensive Care Medicine 10/2018 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.